Mar 15, 2022 Late-Stage Clinical Biopharmaceutical Company with Novel Therapy Platform to Treat Locally Advanced Solid Tumors. Presented at ROTH Capital Partners 34th Annual Conference, March 2022
Mar 2, 2022 Late-Stage Clinical Biopharmaceutical Company with Novel Therapy Platform to Treat Locally Advanced Solid Tumors. Presented at Maxim Virtual Growth Conference, March 2022
Mar 1, 2022 Late-Stage Clinical Biopharmaceutical Company with Novel Therapy Platform to Treat Locally Advanced Solid Tumors. Presented at ROTH Capital Partners 34th Annual Conference, March 2022
Feb 15, 2022 “Delivering Therapy Where it Matters” Fireside Chat with CEO, Shaun Bagai Webinar, February 2022
Jan 15, 2022 Late-Stage Clinical Biopharmaceutical Company with Novel Therapy Platform to Treat Locally Advanced Solid Tumors. Presented at H.C. Wainwright Bioconnect Conference, January 2022
